SCHEMBL8770234

SCHEMBL8770234

CCN(CC)CCCCOc1ccccc1/C(=C(\Cl)c1cccc(O)c1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 9/20 0.49
▸ EBP Q15125 4/20 0.49
▸ ESR2 Q92731 2/20 0.49
▸ DHCR7 Q9UBM7 2/20 0.49
▸ KMT2A Q03164 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ KCNH2 Q12809 2/20 0.48
▸ SIGMAR1 Q99720 2/20 0.48
▸ CHRM2 P08172 2/20 0.48
▸ ADRA2A P08913 2/20 0.48
▸ ADORA3 P0DMS8 2/20 0.48
▸ CHRM1 P11229 2/20 0.48
▸ PTGS1 P23219 2/20 0.48
▸ SLC6A2 P23975 2/20 0.48
▸ SLC6A4 P31645 2/20 0.48
▸ DRD3 P35462 2/20 0.48
▸ HTR6 P50406 2/20 0.48
▸ SLC6A3 Q01959 2/20 0.48
▸ CYP2D6 P10635 2/20 0.48
▸ MEN1 O00255 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8842395 0.89 ESR1 (0.57) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8770654 0.85 ESR1 (0.69) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8770296 0.85 ESR1 (0.69) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8842347 0.85 ESR1 (0.69) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8770364 0.82 ESR1 (0.71) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8842179 0.82 ESR1 (0.71) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8770122 0.82 ESR1 (0.71) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8842353 0.76 ESR1 (0.69) ESR1EBPESR2DHCR7KMT2A
SCHEMBL8899490 0.75 KDM4E (0.64) ESR1EBPESR2DHCR7KMT2A
SCHEMBL14680644 0.75 ESR1 (0.82) ESR1EBPESR2DHCR7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693674-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-12-02 — — US disclosed
US-5691384-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-11-25 — — US disclosed
EP-0794771-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1997-09-17 — — EP disclosed
WO-1996016646-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1996-06-06 — — WO disclosed
Send feedback